Stable knockdown of protein kinase CK2-alpha (CK2α) inhibits migration and invasion and induces inactivation of hedgehog signaling pathway in hepatocellular carcinoma Hep G2 cells

Acta Histochemica

Volumn 116, Issue 8, 2014, Pages 1501-1508

  Wu, Di ^a   Sui, Chengguang ^a   Meng, Fandong ^a   Tian, Xin ^a   Fu, Liye ^a   Li, Yan ^a   Qi, Xinhui ^a   Cui, Huixia ^b   Liu, Yunpeng ^a   Jiang, Youhong ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

CK2 ; EMT process; HCC; Hedgehog signaling pathway; MMPs

Indexed keywords

CASEIN KINASE II ALPHA; GELATINASE A; GELATINASE B; PROTEIN KINASE; PROTEIN PATCHED 1; SHORT HAIRPIN RNA; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR GLI1; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ARTICLE; CANCER INHIBITION; CELL INVASION; CK2ALPHA GENE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; EPITHELIAL MESENCHYMAL TRANSITION; GENE; GENE EXPRESSION REGULATION; GENE SILENCING; HEPG2 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR SIGNALING; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MIGRATION INHIBITION; MOLECULAR PATHOLOGY; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; TRANSCRIPTION REGULATION; UPREGULATION;

ERINACEIDAE; GASTROPODA;

EID: 84919396296     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2014.06.001     Document Type: Article

References (44)

1. Bremnes R.M., Veve R., Hirsch F.R., Franklin W.A. The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis. Lung Cancer 2002, 36:115-124.
2. Cavin L.G., Romieu-Mourez R., Panta G.R., Sun J., Factor V.M., Thorgeirsson S.S., et al. Inhibition of CK2 activity by TGF-beta1 promotes Ikappa B-alpha protein stabilization and apoptosis of immortalized hepatocytes. Hepatology 2003, 38:1540-1551.
3. Chen T., Nie H., Gao X., Yang J., Pu J., Chen Z., et al. Epithelial-mesenchymal transition involved in pulmonary fibrosis induced by multi-walled carbon nanotubes via TGF-beta/Smad signaling pathway. Toxicol. Lett. 2014, 226:150-162.
4. Dauphin M., Barbe C., Lemaire S., Nawrocki-Raby B., Lagonotte E., Delepine G., et al. Vimentin expression predicts the occurrence of metastases in non small cell lung carcinomas. Lung Cancer 2013, 81:117-122.
5. de Herreros A.G., Peiro S., Nassour M., Savagner P. Snail family regulation and epithelial mesenchymal transitions in breast cancer progression. J. Mammary Gland Biol. 2010, 15:135-147.
6. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2002, 2:161-174.
7. Fattovich G., Stroffolini T., Zagni I., Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004, 127:S35-S50.
8. Forner A., Llovet J.M., Bruix J. Hepatocellular carcinoma. Lancet 2012, 379:1245-1255.
9. Fuyuhiro Y., Yashiro M., Noda S., Kashiwagi S., Matsuoka J., Doi Y., et al. Clinical significance of vimentin-positive gastric cancer cells. Anticancer Res. 2010, 30:5239-5243.
10. Gialeli C., Theocharis A.D., Karamanos N.K. Roles of matrix metalloproteinases in cancer progression their pharmacological targeting. FEBS J. 2011, 278:16-27.
11. Gos M., Miloszewska J., Przybyszewska M. Epithelial-mesenchymal transition in cancer progression. Postepy Biochem. 2009, 55:121-128.
12. Haslehurst A.M., Koti M., Dharsee M., Nuin P., Evans K., Geraci J., et al. EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer. BMC Cancer 2012, 12:91.
13. Huang S., He J., Zhang X., Bian Y., Yang L., Xie G., et al. Activation of the hedgehog pathway in human hepatocellular carcinomas. Carcinogenesis 2006, 27:1334-1340.
14. Jia H., Liu Y., Xia R., Tong C., Yue T., Jiang J., et al. Casein kinase 2 promotes Hedgehog signaling by regulating both smoothened and Cubitus interruptus. J. Biol. Chem. 2010, 285:37218-37226.
15. Kim H.S., Chang Y.G., Bae H.J., Eun J.W., Shen Q., Park S.J., et al. Oncogenic potential of CK2 alpha, its regulatory role in EGF-induced HDAC2 expression in human liver cancer. FEBS J. 2014, 281:851-861.
16. Kim J., Hwan Kim S. CK2 inhibitor CX-4945 blocks TGF-beta1-induced epithelial-to-mesenchymal transition in A549 human lung adenocarcinoma cells. PLoS One 2013, 8:e74342.
17. Kumagi T., Hiasa Y., Hirschfield G.M. Hepatocellular carcinoma for the non-specialist. BMJ 2009, 339:b5039.
18. Landesman-Bollag E., Romieu-Mourez R., Song D.H., Sonenshein G.E., Cardiff R.D., Seldin D.C. Protein kinase CK2 in mammary gland tumorigenesis. Oncogene 2001, 20:3247-3257.
19. Li Y., Maitah M.Y., Ahmad A., Kong D., Bao B., Sarkar F.H. Targeting the Hedgehog signaling pathway for cancer therapy. Expert Opin. Ther. Targets 2012, 16:49-66.
20. Litchfield D.W. Protein kinase CK2: structure, regulation and role in cellular decisions of life death. Biochem. J. 2003, 369:1-15.
21. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
22. Rubin L.L., de Sauvage F.J. Targeting the Hedgehog pathway in cancer. Nat. Rev. Drug Discov. 2006, 5:1026-1033.
23. Ruch J.M., Kim E.J. Hedgehog signaling pathway and cancer therapeutics: progress to date. Drugs 2013, 73:613-623.
24. Rundhaug J.E. Matrix metalloproteinases, angiogenesis, and cancer: commentary re: A. C. Lockhart et al., Reduction of wound angiogenesis in patients treated with BMS-275291, a broad spectrum matrix metalloproteinase inhibitor. Clin Cancer Res 2003, 9:551-554.
25. Ruzzene M., Pinna L.A. Addiction to protein kinase CK2: a common denominator of diverse cancer cells?. Biochim. Biophys. Acta 2010, 1804:499-504.
26. Sass G., Klinger N., Sirma H., Hashemolhosseini S., Hellerbrand C., Neureiter D., et al. Inhibition of experimental HCC growth in mice by use of the kinase inhibitor DMAT. Int. J. Oncol. 2011, 39:433-442.
27. Satelli A., Li S. Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol. Life Sci. 2011, 68:3033-3046.
28. Seldin D.C., Lou D.Y., Toselli P., Landesman-Bollag E., Dominguez I. Gene targeting of CK2 catalytic subunits. Mol. Cell Biochem. 2008, 316:141-147.
29. Singh S., Singh P.P., Roberts L.R., Sanchez W. Chemopreventive strategies in hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol. 2014, 11:45-54.
30. Takebe N., Hunsberger S., Yang S.X. Expression of Gli1 in the hedgehog signaling pathway and breast cancer recurrence. Chin. J. Cancer Res. 2012, 24:257-258.
31. Terada T., Okada Y., Nakanuma Y. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors. Hepatology 1996, 23:1341-1344.
32. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2002, 2:442-454.
33. Trembley J.H., Chen Z., Unger G., Slaton J., Kren B.T., Van Waes C., et al. Emergence of protein kinase CK2 as a key target in cancer therapy. Biofactors 2010, 36:187-195.
34. Valcourt U., Kowanetz M., Niimi H., Heldin C.H., Moustakas A. TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol. Biol. Cell 2005, 16:1987-2002.
35. Varjosalo M., Taipale J. Hedgehog: functions and mechanisms. Genes Dev. 2008, 22:2454-2472.
36. Verslype C., Rosmorduc O., Rougier P. Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2012, 23(Suppl 7):vii41-vii48.
37. Vora H.H., Patel N.A., Rajvik K.N., Mehta S.V., Brahmbhatt B.V., Shah M.J., et al. Cytokeratin and vimentin expression in breast cancer. Int. J. Biol. Markers 2009, 24:38-46.
38. Wijnhoven B.P., Dinjens W.N., Pignatelli M. E-cadherin-catenin cell-cell adhesion complex and human cancer. Brit. J. Surg. 2000, 87:992-1005.
39. Yan H.B., Wang X.F., Zhang Q., Tang Z.Q., Jiang Y.H., Fan H.Z., et al. Reduced expression of the chromatin remodeling gene ARID1A enhances gastric cancer cell migration and invasion via downregulation of E-cadherin transcription. Carcinogenesis 2014, 35:867-876.
40. You S., Zhou J., Chen S., Zhou P., Lv J., Han X., et al. PTCH1, a receptor of Hedgehog signaling pathway, is correlated with metastatic potential of colorectal cancer. Ups. J. Med. Sci. 2010, 115:169-175.
41. Younis L.K., El Sakka H., Haque I. The prognostic value of E-cadherin expression in breast cancer. Int. J. Health Sci. (Qassim) 2007, 1:43-51.
42. Zhang S., Long H., Yang Y.L., Wang Y., Hsieh D., Li W., et al. Inhibition of CK2alpha down-regulates Notch1 signalling in lung cancer cells. J. Cell Mol. Med. 2013, 17:854-862.
43. Zhang S., Wang Y., Mao J.H., Hsieh D., Kim I.J., Hu L.M., et al. Inhibition of CK2alpha down-regulates Hedgehog/Gli signaling leading to a reduction of a stem-like side population in human lung cancer cells. PLoS One 2012, 7:e38996.
44. Zou J., Luo H., Zeng Q., Dong Z., Wu D., Liu L. Protein kinase CK2alpha is overexpressed in colorectal cancer and modulates cell proliferation and invasion via regulating EMT-related genes. J. Transl. Med. 2011, 9:97.